Pharmaron acquires clinical CRO
Pharmaron has acquired a majority stake in Shin Nippon Biomedical Laboratories Clinical Pharmacology Center, continuing its strategy of becoming a full service R&D service provider.
Archives for March 1, 2017
Cardboard and brown agglomerates: FDA slams Pfizer injectables plant
Particulate problems in sterile injectables and poor aseptic techniques landed Pfizer with a US FDA warning letter at a former Hospira facility in Kansas.
update
Icon: PRO instruments to improve endpoints for antibacterial drug trials
Icon and the FDA are continuing development of new antibacterial treatments as part of a research project dating back to 2012.
Will deregulation trump clinical trial patient safety?
The Trump administration is looking to massively reduce regulations – which could have major implications for pending guidelines that look to increase clinical trial patient safety.
Metrion ion channel CRO teams up with HTS specialist Assay.Works
Metrion has partnered with Assay.Works for an exchange of ion channels and high-throughput screening (HTS) services for drug discovery.
update - Fosun to relocate production
Fosun-owned API maker Chongqing criticized by US FDA
Lab staff at an API plant run by Chongqing Pharma Research Institute Co., Ltd. deleted out of spec test results according to the US Food and Drug Administration (FDA).
Baxter and ScinoPharm sign injectable oncology drug strategic alliance
Up to 20 injectable cancer drugs will be made at facilities in Taiwan and Germany under terms of a partnership between Baxter and Scinopharm.